Parnaparin: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
No edit summary
 
Line 25: Line 25:
}}
}}
__NOTOC__
__NOTOC__
{{SI}}
{{CMG}}
{{CMG}}


{{SI}}
==Overview==
==Overview==
'''Parnaparin''' is an antithrombotic  agent. It is a low molecular weight hepain.
'''Parnaparin''' is an antithrombotic  agent. It is a low molecular weight hepain.


==External links==
==External Links==
* {{MeshName|parnaparin}}
* {{MeshName|parnaparin}}


==Additional Resource==
==Additional Resource==
* {{cite journal |author=Maugeri N, Di Fabio G, Barbanti M, de Gaetano G, Donati MB, Cerletti C |title=Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood |journal=Thromb. Haemost. |volume=97 |issue=6 |pages=965-73 |year=2007 |pmid=17549299 |doi=}}


* {{cite journal |author=Maugeri N, Di Fabio G, Barbanti M, de Gaetano G, Donati MB, Cerletti C |title=Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood |journal=Thromb. Haemost. |volume=97 |issue=6 |pages=965-73 |year=2007 |pmid=17549299 |doi=}}
==References==
{{reflist|2}}


{{Antithrombotics}}
{{Antithrombotics}}


[[Category:Drugs]]
[[Category:Drug]]
{{WikiDoc Help Menu}}
[[Category:Cardiovascular Drugs]]
{{WikiDoc Sources}}
[[Category:Anticoagulants]]

Latest revision as of 00:49, 26 July 2014

Parnaparin
Clinical data
ATC code
Identifiers
CAS Number
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

WikiDoc Resources for Parnaparin

Articles

Most recent articles on Parnaparin

Most cited articles on Parnaparin

Review articles on Parnaparin

Articles on Parnaparin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Parnaparin

Images of Parnaparin

Photos of Parnaparin

Podcasts & MP3s on Parnaparin

Videos on Parnaparin

Evidence Based Medicine

Cochrane Collaboration on Parnaparin

Bandolier on Parnaparin

TRIP on Parnaparin

Clinical Trials

Ongoing Trials on Parnaparin at Clinical Trials.gov

Trial results on Parnaparin

Clinical Trials on Parnaparin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Parnaparin

NICE Guidance on Parnaparin

NHS PRODIGY Guidance

FDA on Parnaparin

CDC on Parnaparin

Books

Books on Parnaparin

News

Parnaparin in the news

Be alerted to news on Parnaparin

News trends on Parnaparin

Commentary

Blogs on Parnaparin

Definitions

Definitions of Parnaparin

Patient Resources / Community

Patient resources on Parnaparin

Discussion groups on Parnaparin

Patient Handouts on Parnaparin

Directions to Hospitals Treating Parnaparin

Risk calculators and risk factors for Parnaparin

Healthcare Provider Resources

Symptoms of Parnaparin

Causes & Risk Factors for Parnaparin

Diagnostic studies for Parnaparin

Treatment of Parnaparin

Continuing Medical Education (CME)

CME Programs on Parnaparin

International

Parnaparin en Espanol

Parnaparin en Francais

Business

Parnaparin in the Marketplace

Patents on Parnaparin

Experimental / Informatics

List of terms related to Parnaparin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Parnaparin is an antithrombotic agent. It is a low molecular weight hepain.

External Links

Additional Resource

  • Maugeri N, Di Fabio G, Barbanti M, de Gaetano G, Donati MB, Cerletti C (2007). "Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood". Thromb. Haemost. 97 (6): 965–73. PMID 17549299.

References